CareRx Corporation (TSX:CRRX)
3.630
+0.080 (2.25%)
Jul 31, 2026, 3:32 PM EST
CareRx Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, CareRx stock has a consensus rating of "Buy" and an average price target of $5.14. The average 1-year stock price forecast is 41.60% higher than the current stock price, while the lowest is $4.25 (+17.08%) and the highest is $6.25 (+72.18%).
Price Target: $5.14 (+41.60%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CareRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $4.50 | Buy | Maintains | $4.50 | +23.97% | Jul 31, 2026 |
| ATB Cormark Capital Markets | ATB Cormark Capital Markets | Buy Maintains $6.25 | Buy | Maintains | $6.25 | +72.18% | May 11, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $5.50 → $5.00 | Buy | Maintains | $5.50 → $5.00 | +37.74% | May 8, 2026 |
Financial Forecast
Revenue This Year
381.73M
from 370.24M
Increased by 3.10%
Revenue Next Year
404.32M
from 381.73M
Increased by 5.92%
EPS This Year
0.13
from 0.04
Increased by 204.14%
EPS Next Year
0.18
from 0.13
Increased by 40.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.